Pharmafile Logo

Glaucoma in perspective

- PMLiVE

UK report suggests last winter’s Omicron strain was less likely to cause ‘long COVID’

Data from nearly 100,000 people was gathered by a team from King’s College London

Amplifying Opinions of Patients & Caregivers for Higher Quality of Care

Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey...

Impetus Digital

- PMLiVE

Shionogi Europe and NHS England agree on antibiotic subscription model

The antibiotic Fetcroja, along with Zavicefta, will be made available as an option to help address antimicrobial resistance

- PMLiVE

College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system

Led by a group of healthcare leaders and senior politicians, the campaign advocates represcribing and the promotion of social prescribing

- PMLiVE

LifeArc partners with UK Dementia Research Institute

Dementia affects around 900,000 people in the UK and this is expected to rise to around 1.6 million by 2040

6 professional headshots of the 4 women and 2 men on the leadership team at Avalere

Data-driven policy and market access firm Avalere joins Fishawack Health

Fishawack Health bolsters its commercialization service offering with its largest addition to date, welcoming US-based policy, market access, and transformation leader Avalere.

Avalere Health

Icons of a high five between two hands and the logos of PIF and Cuttsy+Cuttsy either side

Cuttsy+Cuttsy gain highly regarded PIF Partner status

As official PIF Partners, Cuttsy+Cuttsy will be supporting the Patient Information Forum raise awareness of the PIF TICK.

Cuttsy + Cuttsy

Science for science sake

Like great works of art, there was no ‘reason’ for certain scientific endeavours, but this ‘just for the sake of it’ philosophy is now delivering tangible benefits. (article written 3rd...

Dice Medical Communications

- PMLiVE

Asking better questions to inform a stronger strategy

Pausing to question the data being used to inform decisions is invaluable in creating better strategy

- PMLiVE

Walking in their shoes

The impact of experiencing what it would be like to have a chronic disease for a day

- PMLiVE

Will that be cash or charge?

India is asking people to pay for booster shots, but extremely poor countries should never consider charging people for public health services

- PMLiVE

EFPIA-EURORDIS joint statement published on patient access to medicines for rare diseases

The statement contains a series of proposals to improve the lives of people living with rare diseases by addressing access barriers to transformative medicines

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links